A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS) ; Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS

YAMAMOTO Hideichiro0 个研究点目标入组 300 人开始时间: 2021年1月29日最近更新: 2023年10月17日

试验速览

暂无简介。

•male or non-pregnant, non-lactating female, age 2 to 35 years,
•- A diagnosis of Lennox-Gastaut syndrome, where seizures that result in drops are not completely controlled by current antiepileptic treatments.
•- All of the following 4 criteria for Lennox-Gastaut syndrome
•- Onset of seizures at 11 years of age or younger.
•- Multiple seizure types (must include TS or TA), including countable motor seizures that result in drops. Countable motor seizure types eligible for inclusion are: GTC, TS, CS, AS, FS with observable motor symptoms, and MS with a drop.
•- Abnormal cognitive development.
•- Evidence of EEG in the medical history that shows abnormal background activity accompanied by slow spike and wave pattern less than 2.5 Hz.

•-Etiology of seizures is a degenerative neurological disease.
•-A history of hemiclonic seizures in the first year of life.
•-Drop seizures in clusters, where individual seizures cannot be counted reliably.
•-Pulmonary arterial hypertension.
•-Current or past history of cardiovascular or cerebrovascular disease, such as cardiac valvulopathy, myocardial infarction or stroke, or clinically significant structural cardiac abnormality, including but not limited to mitral valve prolapse, atrial or ventricular septal defects, patent ductus arteriosis.
•-Current or recent history of Anorexia Nervosa, bulimia, or depression within the prior year that required medical treatment or psychological treatment for a duration greater than 1 month.
•-A current or past history of glaucoma.

发起方

YAMAMOTO Hideichiro